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Introduction
------------

The tonometric determination of the arterial-mucosal PCO~2~-gap (Δa-rPCO~2~) is used to monitor adequacy of gastrointestinal perfusion. As PrCO~2~ also integrates other phenomena \[[@B1]\], we analyzed the influence of the intestinal villus microcirculation on increased Δa-rPCO~2~during long-term hyperdynamic porcine endotoxemia.

Material and methods
--------------------

Anesthetized and ventilated pigs received continuous i.v. endotoxin (ETX, n=12) for 24 h or placebo (Sham, n=6). Hydroxyethylstarch was infused to maintain MAP \>65 mmHg together with a sustained increase in cardiac output \[[@B2]\]. Before the start of ETX (0 h), as well as 12 and 24 h afterwards, portal venous blood flow (Qpv, ultrasound flow probes) and lactate/pyruvate-ratios (L/P pv), ileal mucosal Δa-rPCO~2~ (fiberoptic sensor)and bowel wall capillary Hb-O~2~-saturation (Hb-O~2~cap,remission spectrophotometry) were assessed together with intravital video records of the ileal mucosal microcirculation (number of perfused/not-perfused villi) by orthogonal polarization-spectrometry (Cytoscan^™^) \[[@B3]\] obtained via an ileostomy.

Results
-------

See Table. Median(25/75%); \#*P*\<0.05 vs 0 h (Friedman-Anova); ^§^*P*\<0.05 ETX vs Sham (Mann-Whitney).

Conclusion
----------

Taking into account the unchanged portal venous blood flow, the progressive increase in Δa-rPCO~2~ is mainly due to the heterogeneity of capillary villus perfusion. We can only speculate about the putative additional influence of a disturbed intracellular O~2~-utilisation.

                                           0 h ETX             12 h ETXk                 24 h ETX
  --------------------------------- ------ ------------------- ------------------------- ---------------------------
  Qpv ml/kgxmin                     ETX    24(21,27)           27(22,31)                 26(20,31)
                                    Sham   22(18,25)           26(25,29)                 25(22,29)
  Hb-O~2~cap % (± S.D.)             ETX    51± 16              53± 16                    53± 11
                                    Sham   53± 15              53± 10                    44± 13
  Δa-rPCO~2~ mmHg                   ETX    15(8,17)            18(15,26)\#               22(16,33)\#
                                    Sham   14(9,17)            14(10,16)^§^              13(10,20)
  L/P pv                            ETX    14(13,17)           19(17,22)\#               26(21,31)\#
                                    Sham   11(10,13)           13(8,19)                  14(10,25)
  n (Villi) perfused/not perfused   ETX    60(48;74)/0(0;0)    33(6;52)/28(18;42)\#^§^   32(23;38)/22(10;35) \#^§^
                                    Sham   73(66;130)/0(0;0)   62(54;82)/6(2;11)^§^      55(27;100)/0(0;4)^§^
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